• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 15 (6), 2019
  3. 731-737
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2019 | Volume: 15 | Issue: 6 | Page No.: 731-737
DOI: 10.3923/ijp.2019.731.737

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 186

Authors


Usama Ahmed  Fahmy

Usama Ahmed Fahmy

LiveDNA: 20.22973

Osama Abdelhakim Aly  Ahmed

Osama Abdelhakim Aly Ahmed

LiveDNA: 20.25437

Nabil Abdulhafiz Alhakamy

Country: Saudi Arabia

Keywords


  • Alendronate sodium
  • breast cancer
  • ALS cytotoxicity
  • nanostructured lipid carriers
  • bisphosphonates
  • nanoparticles
  • cancer therapy
  • trans-activating regulatory protein
Research Article

Augmentation of Alendronate Cytotoxicity Against Breast Cancer Cells by Complexation with Trans-activating Regulatory Protein

Usama Ahmed Fahmy Usama Ahmed  Fahmy's LiveDNA, Osama Abdelhakim Aly Ahmed Osama Abdelhakim Aly  Ahmed's LiveDNA and Nabil Abdulhafiz Alhakamy
Background and Objective: Alendronate sodium (ALS) is a member of the class bisphosphonates used to treat osteoporosis. Recent reports suggested that ALS may induce cell death and inhibit the proliferation of estrogen-sensitive MCF-7 breast cancer cells. The aim of this work was the combination of ALS and trans-activating regulatory protein (TAT) loaded nanostructured lipid carriers (NLCs) to potentiate ALS cytotoxicity against MCF-7 breast cancer cells. Materials and Methods: The ALS and TAT were prepared and loaded in NLCs. The formed NLCs were characterized for entrapment efficiency (%) (EE %), particle size and zeta potential. Cell viability was also carried out for the prepared NLCs. Results: The results revealed that the prepared NLCs were spherical, with particle sizes of 285.2±14.1 nm and polydispersity index of 0.51. Zeta potential of ALS-TAT-NLCs was +21.1±3.4 mV. The ALS EE percentage of the prepared NLCs was 12.2±1.1%. At concentration of 10 μg mL–1, the investigated formulations showed cell survival percentage of 6.86, 20.34, 97.53 and 91.55% for ALS-TAT NLCs, raw ALS, raw TAT and plain NLCs, respectively. The IC50 values for the treatments were estimated as follows: ALS-TAT NLCs, 1.98±0.17 μg mL–1, raw ALS, 2.77±0.36 μg mL–1, raw TAT, 1066.67±21.22 μg mL–1 and plain NLCs, 10816.2±112.32 μg mL–1. Conclusion: The combination of ALS with TAT protein loaded NLCs offered a dual mechanism of ALS activity potentiation and a promising candidate for breast cancer therapy.
PDF Fulltext XML References Citation

How to cite this article

Usama Ahmed Fahmy, Osama Abdelhakim Aly Ahmed and Nabil Abdulhafiz Alhakamy, 2019. Augmentation of Alendronate Cytotoxicity Against Breast Cancer Cells by Complexation with Trans-activating Regulatory Protein. International Journal of Pharmacology, 15: 731-737.

DOI: 10.3923/ijp.2019.731.737

URL: https://scialert.net/abstract/?doi=ijp.2019.731.737

Related Articles

Sitagliptin Combined HIV-TAT as Potential Therapeutic Targeting of SARS-CoV-2 Virus

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved